Fredun Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	14,275	8,072	3,142	3,371	3,572	4,057
Market Cap Growth	262.78%	156.94%	-6.80%	-5.63%	-11.97%	119.38%
Enterprise Value	16,047	9,695	4,496	3,993	4,419	4,511
Last Close Price	2589.45	1671.35	667.98	716.04	775.26	912.37
PE Ratio	42.29	24.75	15.92	21.58	33.05	64.04
PS Ratio	2.25	1.27	0.69	0.97	1.30	1.81
PB Ratio	5.13	2.90	2.22	2.78	3.71	5.96
P/TBV Ratio	5.14	2.91	2.23	2.79	3.72	5.97
P/OCF Ratio	119.94	67.82	-	-	-	-
EV/Sales Ratio	2.53	1.53	0.99	1.15	1.61	2.01
EV/EBITDA Ratio	17.67	10.68	8.40	10.50	15.82	32.51
EV/EBIT Ratio	19.42	11.73	9.25	11.64	17.56	38.42
Debt / Equity Ratio	0.87	0.87	1.19	0.87	0.90	0.89
Debt / EBITDA Ratio	2.67	2.67	3.15	2.77	3.10	4.37
Net Debt / Equity Ratio	0.64	0.64	1.15	0.85	0.86	0.86
Net Debt / EBITDA Ratio	1.95	1.95	3.05	2.72	2.98	4.22
Net Debt / FCF Ratio	-2.87	-2.87	-7.19	-12.80	-3.48	-8.78
Asset Turnover	1.13	1.13	1.14	1.23	1.24	1.29
Inventory Turnover	1.85	1.85	1.69	1.70	2.23	3.23
Quick Ratio	0.53	0.53	0.56	0.40	0.27	1.25
Current Ratio	1.68	1.68	1.30	1.54	1.55	2.07
Return on Equity (ROE)	15.55%	15.55%	15.02%	14.34%	13.14%	11.40%
Return on Assets (ROA)	9.14%	9.14%	7.65%	7.59%	7.08%	4.21%
Return on Invested Capital (ROIC)	14.80%	15.10%	13.19%	12.35%	10.15%	8.07%
Return on Capital Employed (ROCE)	23.90%	23.90%	30.50%	24.40%	21.40%	10.40%
Earnings Yield	2.29%	4.04%	6.28%	4.63%	3.03%	1.56%
FCF Yield	-4.32%	-7.64%	-7.23%	-2.40%	-6.69%	-1.64%
Dividend Yield	0.03%	0.04%	0.10%	0.10%	0.09%	0.08%
Buyback Yield / Dilution	-14.78%	-14.78%	-	-3.66%	-7.85%	-4.06%
Total Shareholder Return	-14.75%	-14.74%	0.10%	-3.56%	-7.76%	-3.98%